Blog Posts Categorized: Studies

A recent publication in BioMed Research International has reviewed the study on the potential benefits of Wharton’s jelly derived mesenchymal stem cells in treating a variety of diseases. According to the authors of the review, these stem cells can be collected during millions of births each year at the time of delivery. A huge advantage of this…

A recent publication in Stem Cells Translational Medicine described an open-label phase I clinical trial that was designed to assess the safety of a stem cell therapy for amyotrophic lateral sclerosis (ALS). The specific procedure involved two repeated injections of autologous bone marrow derived mesenchymal stem cells into the spinal canal of patients with ALS. The researchers found…

A recent publication in the Journal of Translational Medicine has highlighted the potential for stem cells to help patients with progressive supranuclear palsy and has proposed measures for testing the safety of stem cell therapy. Like Parkinson’s disease, progressive supranuclear palsy is a neurodegenerative disease that is progressive and characterized by abnormal deposits of the protein tau…

A recent study that followed-up on the condition of patients with advanced pulmonary emphysema three years after they had begun a Phase I clinical trial in which they were treated with a type of stem cell called bone marrow mononuclear cells demonstrated improved symptoms and improved pathology. The idea for using stem cells to treat…

Stem cells are increasingly used in therapies that involve tissue damage because they offer a promising way to replace lost cells and restore lost functions. Another advantage of stem cells over conventional therapies is the ability to use them days, weeks, or months after the stroke. Currently, most therapies for stroke need to be rapidly…